Tyers Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Tyers Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$88K	Buy	7,584 +1,744	+30%	+$18.4K	﹤0.01%	869
2019 Q2	$58K	Buy	5,840 +1,424	+32%	+$15.4K	﹤0.01%	914
2019 Q1	$57K	Hold	4,416	–	–	﹤0.01%	904
2018 Q4	$67K	Hold	4,416	–	–	﹤0.01%	855
2018 Q3	$88K	Hold	4,416	–	–	﹤0.01%	897
2018 Q2	$86K	Hold	4,416	–	–	﹤0.01%	864
2018 Q1	$89K	Buy	4,416 +576	+15%	+$9.74K	﹤0.01%	861
2017 Q4	$51K	Buy	3,840 +864	+29%	+$13K	﹤0.01%	933
2017 Q3	$55K	Buy	2,976 +816	+38%	+$15.2K	﹤0.01%	918
2017 Q2	$40K	Buy	2,160 +1,120	+108%	+$22.2K	﹤0.01%	933
2017 Q1	$24K	Buy	1,040 +48	+5%	+$1.15K	﹤0.01%	936
2016 Q4	$35K	Buy	+992	New	+$29.6K	﹤0.01%	852

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tyers Asset Management's AMAG Position: Q3 2019 in Review

Tyers Asset Management increased its AMAG Pharmaceuticals (AMAG) stake by 30% in Q3 2019, buying an estimated $18.4K and bringing the position to 7,584 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #869.

Tyers Asset Management first reported a position in AMAG in Q4 2016 and has held it in 12 quarters since. The position peaked at $89K in Q1 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Tyers Asset Management held 7,584 shares of AMAG Pharmaceuticals worth $88K as of Q3 2019.
Tyers Asset Management bought 1,744 AMAG Pharmaceuticals shares in Q3 2019, an estimated $18.4K.
AMAG Pharmaceuticals made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #869 holding.
Tyers Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's AMAG Pharmaceuticals position peaked at $89K in Q1 2018.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.